PCSA icon

Processa Pharmaceuticals

18 hedge funds and large institutions have $3.24M invested in Processa Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
18
Holders Change
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.05M 373,598
ACM
2
AIGH Capital Management
Maryland
$853K 303,703
WVP
3
Worth Venture Partners
New Jersey
$251K 70,954
Geode Capital Management
4
Geode Capital Management
Massachusetts
$182K 64,902
VCA
5
Verdence Capital Advisors
Maryland
$168K 59,884
CBA
6
Coastal Bridge Advisors
Connecticut
$148K 52,500 +20,000 +62%
Morgan Stanley
7
Morgan Stanley
New York
$138K 48,951 +48,950 +4,895,000%
Janney Montgomery Scott
8
Janney Montgomery Scott
Pennsylvania
$135K 46,231
State Street
9
State Street
Massachusetts
$120K 42,786 +1,300 +3%
BlackRock
10
BlackRock
New York
$81K 28,617 -471 -2%
Northern Trust
11
Northern Trust
Illinois
$43K 15,401
Renaissance Technologies
12
Renaissance Technologies
New York
$33K 11,600 +11,600 New
VRM
13
Vectors Research Management
New York
$11K 4,000 +4,000 New
Wells Fargo
14
Wells Fargo
California
$9K 3,145 +6 +0.2%
EIM
15
Essex Investment Management
Massachusetts
$6K 2,300 +2,300 New
AF
16
Allworth Financial
California
$5K 1,700
TRCT
17
Tower Research Capital (TRC)
New York
$4K 1,429 -1,705 -54%
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$3K 1,000
SCM
19
Solas Capital Management
Connecticut
-22,844 Closed
UBS Group
20
UBS Group
Switzerland
-1,115 Closed
WT
21
Whittier Trust
California
-22 Closed
CFGS
22
Concourse Financial Group Securities
Alabama